通过目标激活实现的生物直角PROTAC前药物
Mengyang Chang1, Feng Gao2, Devin Pontigon1
1Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.
Journal of the American Chemical Society
|June 16, 2023
概括
这项研究引入了点击释放的PROTACs (crPROTACs),这是一种新型前药策略,可选择性地激活蛋白质分解,向癌细胞中的嵌合体,最大限度地降低毒性并实现向蛋白质降解.
科学领域:
- 生物化学
- 分子生物学
- 化学生物学
背景情况:
- 化向基因组 (PROTACs) 具有治疗潜力,但由于非向蛋白降解而面临毒性问题.
- 制定精确控制PROTAC活动的策略对于最小化副作用至关重要.
- 通过癌症生物标志物激活的前体药物正在探索以提高PROTAC的选择性.
研究的目的:
- 开发一种针对癌细胞的PROTAC激活的生物对等,按需的前药物策略.
- 在癌细胞中创造一种选择性蛋白质降解系统,
- 研究点击释放PROTAC (crPROTAC) 方法的有效性.
主要方法:
- 设计的无活性PROTAC前药物 (TCO-ARV-771,TCO-DT2216) 通过将转环 (TCO) 与VHL E3无酸连接体结合.
- 使用素 (Tz) 修饰的RGD (c(RGDyK) -Tz) 针对癌细胞的整合蛋白αvβ3生物标志物进行前药激活.
- 使用生物直角点击释放机制进行选择性PROTAC激活和随后的蛋白质降解.
主要成果:
- 选择性激活PROTAC前药物是依赖于整体蛋白αβ3的.
- 激活的PROTACs有效地降解了癌细胞内的感兴趣蛋白质 (POI).
- 在不同于非癌细胞的癌细胞中证明了POI的向降解.
结论:
- 通过crPROTAC的策略,可以在目标上激活PROTAC,从而在癌细胞中选择性降解蛋白质.
- 这种生物对等方法提供了一种通过ubiquitin-proteasome途径诱导癌细胞死亡的潜在方法.
- crPROTAC是一种有希望的非生物策略,用于向癌症治疗,并减少非向效应.
相关概念视频
Prodrugs
2.7K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.7K
Targets for Drug Action: Overview
6.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.5K
Drug Biotransformation: Overview
2.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.5K
Principles of Drug Action
6.2K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.2K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Drug-Receptor Interactions
5.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.4K


